(Q44372699)

English

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

John E Levine

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Joseph P Uberti

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lois Ayash

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Christopher Reynolds

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

James L m Ferrara

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Samuel M Silver

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Thomas Braun

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Gregory Yanik

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Raymond Hutchinson

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Voravit Ratanatharathorn

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

189-197

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mixed hematopoietic chimerism after hematopoietic stem cell allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2970009-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(03)70009-3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44372699&oldid=2020533122"